Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
Clinical trial NCT03573648 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03573648
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-13
- Primary completion
- 2026-09-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.